Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

Disease progression prediction and therapeutic drug target discovery for Coronavirus disease 2019 (COVID-19) are particularly important, as there is still no effective strategy for severe COVID-19 patient treatment. Herein, we performed multi-platform omics analysis of serial plasma and urine sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuming, Hou, Guixue, Zhou, Haibo, Wang, Yanqun, Tun, Hein Min, Zhu, Airu, Zhao, Jingxian, Xiao, Fei, Lin, Shanwen, Liu, Dongdong, Zhou, Dunrong, Mai, Lang, Zhang, Lu, Zhang, Zhaoyong, Kuang, Lijun, Guan, Jiao, Chen, Qiushi, Wen, Liyan, Zhang, Yanjun, Zhuo, Jianfen, Li, Fang, Zhuang, Zhen, Chen, Zhao, Luo, Ling, Liu, Donglan, Chen, Chunke, Gan, Mian, Zhong, Nanshan, Zhao, Jincun, Ren, Yan, Xu, Yonghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047575/
https://www.ncbi.nlm.nih.gov/pubmed/33859163
http://dx.doi.org/10.1038/s41392-021-00508-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047575/
https://www.ncbi.nlm.nih.gov/pubmed/33859163
http://dx.doi.org/10.1038/s41392-021-00508-4

Ejemplares similares